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Abstract  
The focus of this Doctor of Nursing Practice project was to target medication adherence in a 
private, rural primary care office, designated as a Rural Health Clinic, in a Tier 1 county in 
central North Carolina. The project site identified that not enough patients with Medicare were 
demonstrating medication adherence to statins, oral antidiabetics, and renin-angiotensin system 
antagonists to achieve a 5-star rating for quality metrics. The purpose of the project was to 
develop and implement a standardized process to increase medication adherence for patients with 
Medicare and increase star ratings in a rural primary care office. The project included a four-part 
intervention to assess for medication adherence and address barriers, to use patient-friendly 
prescription practices, to increase scheduled follow-up visits, and to recapture patients who were 
identified as nonadherent. Findings from the project revealed a significant increase in the star 
rating for oral antidiabetics, the star rating remained stable for the renin-angiotensin system 
antagonists, and there was a slight decrease in the star rating for statins. There were positive 
results for four process measures, including improvement in prescribing prescriptions for 90 days 
or more, scheduling follow-up visits, including diagnosis or procedural codes in the chart, and 
sending prescriptions to a mail-order pharmacy. However, the trend decreased for the number of 
DOSE-Nonadherence measure forms completed during the project period. This project 
contributed to the creation of a quality committee and increased focus on quality measures, laid a 
foundation for improved medication adherence, and demonstrated the importance of nursing 
leadership in improving patient outcomes. 
 Keywords: medication adherence, star ratings, DNP project, primary care, 90-day 
prescriptions 
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Section I.  Introduction 
Background 
 Chronic conditions account for two out of three deaths in the United States (Raghupathi 
& Raghupathi, 2018). Almost 50% of adults have at least one chronic condition, 25% of adults 
have two or more, and almost 50% of older adults have three or more coexisting chronic diseases 
(McPhail, 2016). Prescription medications are a standard treatment for chronic diseases and the 
prevention of their related sequelae; however, medication adherence is suboptimal. Up to 30% of 
new prescriptions are never filled, 50% are not taken as prescribed, and when medications are 
started, adherence rates decline over time (Derenthal et al., 2018; Kleinsinger, 2018). Every year, 
up to 50% of treatment failures, 25% of hospitalizations, and 40% of nursing home admissions 
are related to medication nonadherence (Braithwaite et al., 2013; Kim et al., 2018). Medication 
nonadherence causes up to 125,000 premature and preventable deaths and costs up to $300 
billion annually (Derenthal et al., 2018; Kleinsinger, 2018). For every $1 spent on improving 
medication adherence, there is an estimated $7 savings in disease treatment costs (National 
Council Medical Director Institute, 2018; Pfizer, 2018). Many insurance companies and 
accountable care organizations tie reimbursement and shared-savings program benefits for 
primary care practices to patients’ medication adherence rates (Centers for Medicare and 
Medicaid Services [CMS], 2021; Independence Blue Cross 2017). 
Organizational Needs Statement 
The project site for the Doctor of Nursing Practice (DNP) project was a rural, private 
family practice office. Their practice goals were improving healthcare quality, promoting value-
based care, and focusing on preventive care and chronic disease management (site champion, 
personal communication, September 16, 2020). Medication adherence plays a significant role in 
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chronic disease management because it improves clinical outcomes, reduces undesirable 
sequelae, reduces hospitalizations, enhances the quality of life, reduces premature deaths, and 
decreases total healthcare costs (Kim et al., 2018). Because medication adherence is an essential 
element of chronic disease management, it is a significant factor in healthcare quality metrics 
and practice reimbursement. The practice site earned star ratings on quality metrics for 
medication adherence to statins, oral antidiabetics, and renin-angiotensin system antagonists 
from Blue Cross Blue Shield (BCBS, site champion, personal communication, 2020). The 
project site’s organizational need was to improve medication adherence to statins, oral 
antidiabetics, and renin-angiotensin system antagonists for patients with Medicare and increase 
their star ratings. 
Star Ratings 
The Five-Star Quality Rating System was created by CMS to improve Medicare 
Advantage plan members’ quality of care (CMS, 2021). They identified quality measures to 
improve patient care quality and then rate healthcare providers’ performance in meeting them. 
BCBS adopted the Five-Star Quality Rating System and set goals for primary care provider 
practices to strive to achieve (Independence Blue Cross, 2017). Star rating scores range from 1-5 
stars, from lowest to highest (Bajner et al., 2018). Implementing the star rating system 
encouraged organizations to improve their quality of care and offered financial reimbursement 
and rewards to incentivize organizations to improve their star rating (CMS, 2021). Primary care 
offices are reimbursed at a base rate regardless of the star rating; however, an average star rating 
bonus is payable when the average star rating increases above a predefined threshold.  
BCBS calculated star ratings for the quality measures for the project site (site champion, 
personal communication, November 6, 2020). The project site needed to meet or exceed 4 stars 
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from BCBS to qualify for the average star rating bonus at the end of each year (Blue Cross Blue 
Shield of North Carolina [BCBSNC], 2018). The average star rating determined the annual 
bonus amount, which increased with every quarter of a point, with a score of 4.75 stars and 
above earning the maximum bonus amount.  
The average star rating comprised 10 individual quality measures that each earned star 
ratings. The individual star ratings were weighted by importance as either single- or triple-
weighted. Triple-weighted measures contributed three times their rating toward the average star 
rating (BCBSNC, 2018). The project site desired to achieve a 5-star rating for all 10 quality 
measures to earn an overall 5-star rating. However, this project focused on the three quality 
measures that pertained to medication adherence. 
Medication Adherence 
Medication adherence is considered critical to improving patient outcomes and quality. 
Therefore, the medication adherence quality measures for statins, oral antidiabetics, and renin-
angiotensin system antagonists included in the average star rating were triple-weighted by BCBS 
(BCBSNC, 2018). The three medication adherence quality measures accounted for 45% of the 
project site’s average star rating from BCBS (site champion, personal communication, October 
13, 2020). The star ratings the project site earned for medication adherence to statins, oral 
antidiabetics, and renin-angiotensin system antagonists were, in order, 3, 2, and 3 in December 
2020 for BCBS (site champion, personal communication, February 9, 2021). 
Medication adherence is the degree to which an individual follows the interval and 
dosing instructions and correctly takes their prescribed medication (Pfizer, 2018). A patient’s 
medication adherence percentage is determined by pharmacy claims data (Farley et al., 2019). To 
be adherent, a patient must fill their prescription(s) at least as frequently as enough to have the 
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medication on hand for a minimum of 80% of the time they should be taking it, called the 
proportion of days covered (CMS, 2021). BCBS set the benchmarks for the percentage of 
patients qualifying for medication adherence to earn star ratings. The thresholds progressively 
increased to earn higher star ratings.  
Healthy People 2030 
With the focus on medication adherence, this project aligned with the goals of Healthy 
People 2030. They provide guidance for the nation concerning health promotion and disease 
prevention (National Center for Health Statistics, 2020). The new initiatives, published in 2020, 
focused on the causes of health outcomes, upstream measures, matters of national importance, 
high priority public health issues, and select social determinants of health (Healthy People 2030, 
n.d.). Healthy People 2030’s health indicators address medication adherence directly and 
indirectly (National Academies of Sciences, Engineering, and Medicine, 2020). Directly, 
medication adherence is addressed in two objectives included in the topic of Access to Health 
Services. First, they advocate reducing the number of persons who cannot obtain or delay in 
obtaining medical care. Secondly, they seek to reduce the number of persons who cannot obtain 
or delay in obtaining their prescribed medications. Indirectly, many indicators are influenced by 
improving chronic disease management.  
Healthy North Carolina 2030 
By focusing on medication adherence, this project indirectly aligned with Healthy North 
Carolina 2030. The Healthy North Carolina 2030 publication serves as North Carolina’s 
population health improvement plan (North Carolina Institute of Medicine, 2020). This project is 
related most closely to the 21st health indicator: Life Expectancy. Life expectancy is a good 
measure of the cumulative outcomes of the health of a population. Therefore, anything that 
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impacts life expectancy, such as chronic disease management, applies to this indicator. The life 
expectancy among the counties of North Carolina ranged from 73.1 to 82.1 years. The project 
site’s county had an average lifespan of only 73.1 to 75.9 years, which is the lowest category in 
North Carolina.  
Triple Aim 
The project’s focus on medication adherence aligned with the Institute for Healthcare 
Improvement’s Triple Aim (IHI, n.d.-b). The Triple Aim focuses on healthcare improvement and 
optimizing health system performance by reducing healthcare costs, improving population 
health, and delivering high quality care. This project’s focus on medication adherence proposed 
meeting these objectives through quality chronic disease management to reduce morbidity and 
mortality and decrease avoidable sequelae. In addition, focusing on medication adherence at the 
project site aims to reduce the costs associated with uncontrolled disease states, improve their 
population’s health, and provide high quality care to patients.  
Problem Statement  
 Medication nonadherence contributes to morbidity and mortality, causing poorer 
outcomes and increasing healthcare costs. As a result, insurance organizations are linking 
reimbursement and incentives to medication adherence performance. The individual star ratings 
for the three quality metrics related to medication adherence accounted for almost half of the 
average star rating (site champion, personal communication, February 9, 2021). BCBS set 
benchmarks for the project site to achieve a specified percentage of their patients who met the 
target for medication adherence for individuals on Medicare. The problem was that not enough 
patients with Medicare demonstrated medication adherence for the project site to achieve a 5-star 
INCREASING MEDICATION ADHERENCE  11 
rating for medication adherence to statins, oral antidiabetics, and renin-angiotensin system 
antagonists from BCBS as their star ratings ranged from 2-3 stars in December 2020. 
Purpose Statement 
The purpose of this DNP project was to develop and implement a standardized process to 
address medication adherence in patients with Medicare in a rural primary care office. The 
project sought to improve the quality of care for patients, increase the percentage of persons with 
Medicare who met the benchmarks set by BCBS, and increase the project site’s star ratings for 
the quality metrics of medication adherence to statins, oral antidiabetics, and renin-angiotensin 
system antagonists.  
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Section II. Evidence  
Factors Affecting Medication Adherence 
There are many barriers to medication adherence and factors in nonadherence. The World 
Health Organization (WHO) developed a framework to understand the factors that influence 
nonadherence (Alvi et al., 2019; Centers for Disease Control and Prevention [CDC], 2017). They 
described and categorized the factors into five dimensions, and researchers continue to define 
them using the WHO’s framework (Devine et al., 2018; Gast & Mathes, 2019). The framework 
comprises five dimensions of factors in nonadherence, including those related to the individual; 
the prescribed therapy; the disease or condition; the healthcare team, system, and processes; and 
social, economic, and political conditions and policies (Alvi et al., 2019; CDC, 2017). 
Patient-related factors are the first dimension affecting adherence. These factors are 
affected by the individual patients, and incorporate their knowledge, attitude, motivation, beliefs, 
values, and expectations (CDC, 2017). Factors under this domain include mistrust of or 
dissatisfaction with doctors and medicine, views about medications and chronic illnesses, and 
concerns about the possible side effects of taking pills or drugs (Devine et al., 2018; Yap et al., 
2016). Cognitive factors such as mental and physical comorbidities, depression, alcohol abuse, 
substance abuse, and advancing age also affect medication adherence (Devine et al., 2018; Gast 
& Mathes, 2019). Feeling well during the early stages of chronic illnesses or the lack of 
symptoms may adversely contribute to the perception of an illness’s risks or a medication’s 
benefits (Devine et al., 2018; Yap et al., 2016). Finally, forgetfulness is a significant obstacle to 
medication adherence, resulting from a lack of a routine, education, or time, and is the most 
commonly reported factor (Chan et al., 2020; Devine et al., 2018; Yap et al., 2016). 
INCREASING MEDICATION ADHERENCE  13 
Therapy-related factors are the second domain affecting adherence. These factors are 
related to the medical regimen and include complexity, duration, prior failures, frequent changes, 
and adverse reactions (CDC, 2017). Barriers related to therapy include the need to change 
preexisting routines, conduct regular disease monitoring, and manage difficult and or painful 
monitoring requirements such as frequent blood glucose testing (Chan et al., 2020; Devine et al., 
2018). Complex medication regimens such as a high daily pill burden, frequent dosing, an 
increased number of medications, and a necessity for routine drug calculations, all contribute to 
the difficulty of adhering to provider recommendations (Chan et al., 2020; Gast & Mathes, 
2019). Therapy-related factors include complicated and hard-to-open drug packaging, generic 
and trade naming convention, and formulation challenges such as large pills or needing to cut 
pills in half (Chan et al., 2020; Yap et al., 2016). 
Disease-related factors are the third domain affecting adherence. These factors are related 
to the demands of the illness. These can include the severity, level of disability, expected or 
actual progression, and possible treatments for the disease (CDC, 2017). Barriers in this domain 
are also concerned with the condition’s duration and the expected length of treatment needed 
(Gast & Mathes, 2019). Other disease-specific factors include a lack of an immediate 
improvement in the perceptions of symptoms or overall health and the destructive interplay 
between comorbid conditions, which exacerbate each other (Chan et al., 2020). Coexisting and 
multiple conditions require sustained, intensive, and long-term treatments and usually have an 
unfavorable course if not managed well. Other disease factors include the risks for and effects of 
hospitalization, the compounding effects of sequelae resulting from uncontrolled disease states, 
interruptions to drug regimens, the necessity for frequent medication changes, inefficient or 
absent medication reviews, and induction of polypharmacy (Yap et al., 2016). 
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Healthcare system-factors are the fourth domain affecting adherence. These factors are 
related to the healthcare team, systems, and processes (CDC, 2017). These can be related to a 
lack of access and quality of healthcare services, lack of or poor communication, lack of provider 
training, unsatisfactory patient involvement, and a lack of adequate patient education. Low 
health literacy is another factor associated with a lack of knowledge about the disease state, 
expected outcomes, and medication instructions, such as the intended schedule, dose, interval, 
timing, and indication (Devine et al., 2018). Health insurance plan coverage, copayments, cost-
sharing, drug formularies, and medication costs are system-level factors that present significant 
barriers for some patients (Gast & Mathes, 2019). Lack of available healthcare due to the timing 
of office hours, location of facilities, distance to care, lack of transportation, and insurance 
requirements such as payer networks can negatively affect access and potentially prohibit 
adequate follow-up (CDC, 2017). The lack of time spent with patients, the complexity of 
treatment plans, and provider-patient relationships are also factors. 
Social and economic factors are the fifth domain affecting adherence. These factors are 
concerned with social, economic, and political conditions and policies (CDC, 2017). The number 
of factors in this domain is vast. These include factors related to age, race and ethnicity, 
socioeconomic status, educational attainment, unemployment levels, social support networks, 
and living conditions. The WHO emphasizes the socioeconomic and political context people live 
in as these factors interact with and contribute to the social determinants of health (White-
Williams et al., 2020). These influence individuals through governmental, economic, social, and 
public policies and cultural and societal values. Social factors include an array of influencing 
elements, including religious and cultural beliefs and practices, sex and gender inequalities, 
societal expectations, and stigmas associated with some diseases and medication classes (Chan et 
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al., 2020; Devine et al., 2018). Adherence is affected by marital and family statuses, lack of 
social support or network, the presence of or lack of a caregiver, and family dysfunction (Devine 
et al., 2018). Economic barriers in this domain include a lack of money and resources, 
unemployment or underemployment, high medication costs, travel expenses, lost work time, and 
insurance deductibles and coinsurance requirements. Financial status, occupation, income levels, 
and competing financial obligations can all affect adherence (White-Williams et al., 2020). Other 
social and political conditions include national and state policies, voluntary and forced migration, 
undocumented status, and even the effects of war (Shahin et al., 2020; White-Williams et al., 
2020). 
Barriers to medication adherence and factors in nonadherence are extensive and too 
numerous to list comprehensively. Individuals may experience one or multiple barriers 
simultaneously. One systematic review by Devine et al. (2018) posited that all factors could stem 
from or be related to systems-level factors. For example, they reframed patient-related factors 
and suggested the factors were a really a result of providers’ inadequate effort to address 
patients’ comorbidities and substance abuse or consider their values, beliefs, and cultural 
practices when prescribing care plans. They further suggested that this lack of concordance 
between the patient’s expectations for, knowledge about, and understanding of the provider’s 
orders causes patients to be nonadherent (Devine et al., 2018).  
Literature Review  
 The project lead conducted a literature review of medication adherence. The PICOT 
(Population, Intervention, Comparison, Outcome, Time) method was used to identify the search 
question and discovered three concepts for integration in the literature search. The concepts were 
medication adherence, chronic disease, and family practice. Subject terms were identified by 
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searching the database language with keywords for each database and new keywords prompted 
amended searches for subject terms in the other databases for continuity. The subject terms were 
recorded in a concept table. Medication adherence was the first concept and included the 
following search terms: medication adherence, medication compliance, patient compliance, and 
noncompliance. Chronic disease was the second concept and included the search terms: chronic 
disease and chronic illness. The third concept, primary care, included the search terms: primary 
health care; physicians, primary care; physicians, family; and practitioner’s office.  
The project lead conducted literature searches in five databases, including Ovid, the 
Cumulative Index of Nursing and Allied Health Literature (CINAHL), PubMed, ProQuest, and 
Google Scholar. The Ovid, CINAHL, PubMed, and ProQuest searches were performed using the 
identified database’s search terms. The Google Scholar search included the keywords used to 
find the subject terms from the Ovid, CINAHL, PubMed, and ProQuest database searches. The 
search stream entered into the search bar on Google Scholar was: “medication adherence” or 
“medication compliance” or “patient compliance” and “chronic disease” or “chronic illness” or 
“chronic condition” and “primary care” or “family practice” or “practitioner.”  
Before applying search limits, there were 81 results from CINAHL, 91 from Ovid, 71 
from PubMed, 30 from ProQuest, and 29 from Google Scholar, for a total of 302 total search 
results (see Appendix A). Search limits were applied, including a publication date between 2015 
and 2020 and an English language restriction. The applied limits reduced the number of articles 
returned to 35 from CINAHL, 41 from Ovid, 46 from PubMed, 25 from ProQuest, and 29 from 
Google Scholar, for 179 remaining articles.  
Then, an initial review of the 179 articles’ titles and abstracts was conducted to identify 
those warranting a full article review. An article was selected for full review if the title or 
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abstract mentioned an intervention related to medication adherence. Of these, 65 articles 
remained. For the article to be retained during the full review, the article had to detail an 
intervention for medication adherence. The full review resulted in the retention of 40 articles, 
and all others were excluded as not related to the project. Data from the 40 articles were entered 
into a literature matrix for categorization and synthesis (see Appendix B).  
 The Levels of Evidence designed by Melnyk and Fineout-Overholt (2015) were used to 
evaluate the 40 retained articles per their Levels of Evidence I through VII. The design and 
sample data were used in determining the article’s Level of Evidence. The literature review 
results included an array of articles with evidence from nearly all the Levels of Evidence. Of the 
articles, two were Level I, three were Level II, eight were Level III, seven were Level IV, none 
were Level V, 12 were Level VI, and eight were Level VII. The literature review identified two 
significant themes: identifying medication adherence and treating medication adherence. Eleven 
of the articles focused on screening for medication adherence and identifying barriers. The other 
29 articles recommended a specific action(s) for medication adherence. 
Current State of Knowledge  
Medication adherence has been a frequent topic in the literature since the first study was 
published in 1968 (Costa et al., 2015). Now, 50 years later, after many studies and attempted 
interventions, we have fallen short with an abundance of literature but little success in effectively 
changing medication adherence rates (Costa et al., 2015; Kleinsinger, 2018). Unfortunately, 
despite small statistically significant results, nearly all studies show minimal to no practical 
change in medication adherence rates (Costa et al., 2015). Medication adherence rates continue 
to hover around 50% and have not changed appreciably. 
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Current Approaches to Measuring Medication Adherence 
 Medication adherence includes the initiation, implementation, and discontinuation of 
pharmacotherapeutic treatment (Lam & Fresco, 2015). Primary nonadherence occurs when an 
individual does not fill their prescription. Secondary nonadherence occurs when the medication 
is not taken as prescribed. Attempts have been made to measure medication nonadherence using 
either subjective or objective measures. Subjective measures include the patient’s estimation of 
medication adherence or the provider’s evaluation of their behavior, which both tend to 
overestimate adherence. Objective measures include techniques such as counting pills, 
employing electronic monitoring, performing secondary database analyses such as pharmacy 
records and insurance claims, and obtaining biochemical measurements in body fluids.  
Adherence measures are further categorized as direct and indirect measures. Direct 
measures include testing for the presence of metabolites or biomarkers in body fluids or direct 
observation of medication administration (Lam & Fresco, 2015). Direct measures do not reveal 
medication adherence patterns over time, are costly, and are invasive, limiting their usefulness. 
Indirect measures include performing secondary database analyses of electronic prescription and 
insurance records to calculate medication-taking behavior. Refill adherence assumes that the 
refills reflect the medication behavior and that the medications are taken as prescribed. Two 
common measures using electronic databases include the medication possession ratio and the 
proportion of days covered. The medication possession ratio measures the number of days’ 
supply of the medication the patient has. The proportion of days covered measures the frequency 
of refills and is commonly used to determine medication adherence. The benefits of using 
electronic prescription records are that it allows for assessing large populations and multidrug 
adherence.  
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 Other indirect methods to calculate adherence include electronic medication packaging, 
conducting pill counts, clinician judgement, and patient self-reports (Lam & Fresco, 2015). 
Electronic medication packaging incorporated devices that measure when the container has been 
accessed by recording each event’s date and time. Pill counts are conducted by counting the 
number of pills remaining between two consecutive visits relative to the number prescribed. 
Clinician assessments and patient self-reports include several subjective measures that are the 
least reliable but are the simplest and fastest to use. Available methods include using a patient-
kept diary, patient interviews, and questionnaires and scales.  
More than 40 self-report scales are used for medication adherence, and currently there is 
no gold-standard (Lam & Fresco, 2015). Some of the most common tools include the Brief 
Medication Questionnaire, the Hill-Bone Compliance Scale, the 8-item and 4-item Morisky 
Medication Adherence Scales, the Medication Adherence Questionnaire, the Medication 
Adherence Report Scale, and the Domains of Subjective Extent of Nonadherence (DOSE-
Nonadherence) measure (Lam & Fresco, 2015; University of Wisconsin, 2019). While most of 
the tools measured some combination of behaviors, barriers, or beliefs about medication 
adherence, each had some significant limitations (Lam & Fresco, 2015). For example, the Brief 
Medication Questionnaire is time-consuming to administer. The Hill-Bone tool has limited 
generalizability. The Morisky Medication Adherence Scales and the Medication Adherence 
Questionnaire instruments are expensive to implement. The Medication Adherence Report Scale 
has limited generalizability. However, the DOSE-Nonadherence measure tool is unique because 
it has been validated in the presence of many chronic diseases and is free for use under a signed 
license agreement (University of Wisconsin, 2019). 
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Current Approaches to Solving Medication Nonadherence   
Attempts to solve medication nonadherence have revolved around individual 
interventions to impact the WHO’s five domains of adherence. These interventions have been 
classified as behavioral, educational, self-management, risk communication, packaging and daily 
reminder aids, and integrated care interventions (Costa et al., 2015). Behavioral interventions 
focus on changing a single, specific individual’s behavior, often using cognitive-behavioral 
techniques to promote medication adherence. Personalized behavioral interventions have 
targeted actions via intensive medication education and counseling (Mantri, 2015; Yoon et al., 
2020), barrier identification (Kvarnström et al., 2018), and motivational interviewing (do Valle 
Nascimento et al., 2017; Ruiz Moral et al., 2015). Using values clarification, conducting a 
medication adherence assessment, and tailoring medication therapy to the patient’s goals for a 
personalized treatment plan can increase medication adherence (Holmes et al., 2016).  
Educational approaches have emphasized patient education, communication, and the 
patient-provider relationship (Costa et al., 2015). It is recommended that primary care providers 
give the reason for medication selection, rationale, dosing schedule, and possible side effects in a 
way the patient understands and can follow for medication adherence to be viable (Fernandez-
Lazaro et al., 2019). Techniques to improve the patient-provider relationship and appropriately 
place the individual as the focus of their treatment plan include a person-centered approach, 
motivational interviewing, and shared decision-making (Bosworth et al., 2016; Voshaar et al., 
2015). These strategies ascribe a stronger emphasis on the provider’s responsibility to focus on 
the patient and make the patient the center of the treatment plan while assessing ways to improve 
medication adherence. Gogovor et al. (2019) recognize that educational and knowledge-based 
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interventions alone have had limited effectiveness and wrote that 90% of individuals in their 
study reported that they understood the directions for taking their medications. 
Risk communication interventions are intended to address intentional nonadherence due 
to poor risk perception (Costa et al., 2015). The patient and the provider often view the risk 
associated with chronic conditions quite differently; thus, strategies that bolster this aspect of 
medication adherence may be effective. A written treatment plan is one intervention that may 
improve medication adherence in chronic conditions (Hale et al., 2018; Holdsworth et al., 2019). 
For example, asthma action plans are used frequently. However, these have mixed results 
regarding whether they improve medication adherence (Kelso, 2016), but they may be an asset 
when working with some patients. Printed materials such as brochures, pamphlets, and online 
health information may be used to increase disease awareness, progression, and the dangers of 
undertreatment or nontreatment (Huang et al., 2019; Park et al., 2020; Voshaar et al., 2015). To 
make informed decisions, patients must have adequate information and understanding of the 
disease process and potential sequelae. 
Self-management has a significant role in medication adherence in the literature 
(Kvarnström et al., 2018; Voshaar et al., 2015). Interventions that target self-management range 
from topics devoted to self-efficacy, self-care, and health literacy to self-monitoring via 
technology-based programs, phone applications, wearable devices, and telehealth visits (Costa et 
al., 2015). Self-management interventions that have been explored include the presence of family 
and friend support (Huang et al., 2019), degree of health literacy (Klinovszky et al., 2019; 
Voshaar et al., 2015), group self-management courses (S. Cutler et al., 2018), and locus of 
control (Klinovszky et al., 2019). One study successfully improved A1c and blood pressure 
levels using a medication self-management program (Kim et al., 2020). An exploding area of 
INCREASING MEDICATION ADHERENCE  22 
research in medication adherence is the role of technology and how it applies to self-
management, including smartphone apps (Armitage et al., 2020), text messaging (Khan et al., 
2017), telehealth visits (Wu et al., 2019), and digital health technologies and wearable devices 
(Khan et al., 2017). As more products become available and individuals choose to incorporate 
their health and wellness with technology, more research will need to be completed to determine 
whether these changes will increase medication adherence. Also, consideration will need to be 
given to how these will affect individuals in rural areas with limited access to smart devices and 
internet access. 
Using aids such as special packaging and daily reminders is a practical approach to 
unintentional nonadherence by reminding individuals when it is time to take their medication, 
attend appointments with providers, or reorder prescriptions (Costa et al., 2015). One method 
that showed a significant increase in medication adherence had a nurse call to check on patients 
with hypertension twice a month to monitor and promote chronic disease control. Another 
intervention used prescheduled follow-up visits and placed phone calls to patients if they missed 
their appointment and to those who needed to schedule a visit (Ballo et al., 2018). Another 
approach, trialed by the U.S. Department of Veterans Affairs, was to have daily monitoring of 
patients with heart failure via the use of a home telehealth program (Guzman-Clark et al., 2020). 
Other reminder aids include devices like alarms, wearable devices, pill organizers, and electronic 
devices such as pillboxes (Choi, 2019). Some electronic devices will upload data directly into 
electronic health records for medical providers to review (Dinh-Le et al., 2019). Convenience 
packaging from the pharmacy, in which the medications are prepackaged in blister packs and 
sorted by time of day, has been an effective intervention, though it can be costly (Conn et al., 
2015). 
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Integrated care interventions are the last classification of interventions, and these 
interventions show the most promise for increasing medication adherence rates. Integrated care, 
also known as care management, is a care delivery model in which an entire health system, 
managed between many different disciplines, provides care for the whole person (WHO, 2016). 
This approach incorporates multidisciplinary teams from many sectors affiliated with health care 
to solve complex problems. One integrated care intervention was conducted at the Veteran’s 
Health Administration to calculate the impact on medication adherence by forming a program for 
primary intensive care management (Yoon et al., 2020). Unfortunately, they did not see changes 
in medication adherence except in one class of antidiabetic.  
Medical homes are another way to provide comprehensive care while utilizing a team 
approach. One example is the medical home program created by North Carolina for individuals 
covered by Medicaid (Beadles et al., 2015). One study compared the effects of medical home 
enrollment with medication adherence and found that those enrolled had better rates by 3-6% 
than those who were not enrolled. Another study reported on medication adherence rates in a 
medical home and noted increased medication adherence rates at one year in patients who were 
enrolled (Lauffenburger et al., 2017). Kim et al. (2020) conducted an interprofessional 
multifactorial intervention that targeted medication self-management. Though they did not 
measure medication adherence directly, they demonstrated improved blood pressures and A1c 
measurements, which they reported were due to better medication management (Kim et al., 
2020). 
The final example of integrated care interventions was published by Kaiser Permanente, 
an extensive health system in the United States (Schmittdiel et al., 2015). This organization 
desired to address the core measures related to the star quality-rating system from CMS and 
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designed system-level interventions to improve the medication adherence rate to 80% in all their 
locations. They found a longer prescription duration of greater than or equal to 90 days per 
prescription to be the largest predictor for medication adherence. Other successful strategies 
were using mail-order pharmacies, keeping copays less than or equal to $10, and annual out-of-
pocket costs less than or equal to $2,000 annually. More patient-friendly prescription services are 
recommended as an effective systems-level way to improve medication. Effective prescription 
interventions included greater pharmacist participation (Beadles et al., 2015), longer duration of 
prescription for 90 days or more (King et al., 2018), using a single pharmacy (Pagès-Puigdemont 
et al., 2019), and utilizing mail delivery (Yoon et al., 2020).  
In the end, despite a vast amount of research on medication adherence, it is a multifaceted 
and multifactorial challenge facing healthcare, and no simple interventions have been found. The 
varied and individualized factors demonstrate that targeting medication adherence will need to 
include systems-level changes, patient-centered care, and an individualized plan of care that 
addresses the patient’s factors and their barriers to medication adherence 
Evidence to Support the Intervention 
Due to the overwhelming complexity and interplay between contributing factors, no 
single intervention has dramatically improved medication adherence rates. Consequently, a 
multidimensional, multifactorial approach is needed to improve medication adherence 
significantly. Success has been demonstrated by Kaiser Permanente (2016), as they reported 
improved medication adherence rates to achieve star ratings of 4 and 5 for all their facilities after 
implementing a health-system-level initiative. They achieved improved medication adherence for 
all three of their facilities and provided strong evidence that their initiatives worked and are 
worth replicating. Thus, the project site desires to implement a similar systems-level intervention 
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that addresses medication adherence with the successful interventions used by Kaiser 
Permanente while customizing them to the local population’s needs. 
The best approach for a systems-level intervention, advocated by Kaiser Permanente, was 
to focus on modifiable barriers at the health system level while assisting individuals at the same 
time. They recommend including five specific interventions: changing prescription-writing 
practices, decreasing copays and out-of-pocket costs, offering online refill requests, using 
automated phone reminders, and utilizing mail order pharmacy (Kaiser Permanente, 2016). 
Changing prescription practices alone almost doubled the likelihood that the patient would meet 
the 80% PDC requirement (Schmittdiel et al., 2015). The prescription practices that made the 
most significant difference were to write prescriptions for 90 days or more, write for generics 
that cost $10 or less, use a mail-order pharmacy, and keep total expenses per year under $2,000. 
The project site intends to implement these interventions except for the automated phone 
reminders. The project site has used automated phone reminders in the past and did not find it 
useful. Also, the site does not have broad access to pharmacy refill information, and many 
pharmacies provide this service to their customers (medical director, personal communication, 
October 7, 2020).  
Screening for medication adherence allows for assessment of the factors and barriers each 
individual faces in their health context. Understanding what influences medication nonadherence 
is essential because it facilitates shared decision-making and effective patient-centered 
interventions (Pagès-Puigdemont et al., 2019). The project site will incorporate the DOSE-
Nonadherence measure to screen patients for medication nonadherence (site champion, personal 
communication, November 11, 2020). This tool demonstrated validity across multiple disease 
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conditions, intended to screen for medication nonadherence, and was low cost to utilize for the 
project site.  
Evidence-Based Practice Framework 
The Health Belief Model 
The underlying theory used for this project is the Health Belief Model. This model was 
derived from the social cognitive branch of psychology and was initially developed in the 1950s 
to explain why people would not engage in health behaviors that could prevent disease even 
when they were relatively low cost or even free (Rosenstock, 1974). It was later applied to sick-
role behavior, health decisions made after a diagnosis of a disease has been established (Becker, 
1974). The Health Belief Model has been applied to actions such as screenings, risk behaviors, 
vaccinations, contraceptive use, diet and exercise, dental behaviors, well-child visits, physician 
visits, and chronic disease management, particularly related to treatment adherence for 
hypertension, diabetes, renal disease, obesity, asthma, and psychiatric disorders (Abraham & 
Sheeran, 2015).  
The Health Belief Model was expanded to include three domains that affect each other, 
and include modifying factors, individual beliefs, and actions (Champion & Skinner, 2008). The 
modifying factors influence the individual’s beliefs, which, in turn, influence the individual’s 
actions (Champion & Skinner, 2008). Modifying factors is the first domain and includes 
demographic variables such as age, gender, race and ethnicity, socioeconomic status, education, 
and psychological factors such as personality, peer pressure, and locus of control (Abraham & 
Sheeran, 2015). Individual beliefs is the second domain and encompasses perceptions of the 
threat of illness, including perceived susceptibility and severity, general health motivation, and 
an evaluation of behaviors that counteract the threat, including the perceived benefits and 
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barriers. Actions is the third domain, and it is influenced by cues to action and an individual’s 
self-efficacy.  
In a review of studies using this model, results showed that the most reliable predictor of 
behavior in chronic diseases, known as sick role behavior, was the existence of barriers, followed 
by disease severity, benefits third, and then susceptibility. This project sought to find ways to 
influence individuals to embrace health behaviors that would increase medication adherence and 
decrease chronic conditions' sequelae. The Health Belief Model suggested that focusing on 
barriers, severity, benefits, and susceptibility should be considered along with health motivation; 
thus, it was a useful framework to guide the project. 
The IHI Model for Improvement 
  The Institute for Healthcare Improvement’s (IHI) Model for Improvement was used as 
the operational framework. The IHI’s Model for Improvement uses three questions and the plan-
do-study-act (PDSA) cycle (IHI, n.d.-a). The first question identifies the intended goal by asking 
what the desired outcome is. The second question seeks to identify what data will need to be 
collected by asking how the change will be identified. The third question seeks to determine 
what changes could be tested by asking what solutions might improve the process. The PDSA 
cycle is used to evaluate the changes (IHI, n.d.-a). Each cycle ends by determining whether the 
change should be adapted, adopted, or abandoned, and subsequent cycles are repeated. The 
results are used to determine the next testing cycle.  
The Model for Improvement was used to focus on systems-level changes and optimize 
health system performance and aligned with the Triple Aim’s goals to reduce healthcare costs, 
improve population health, and ensure patient satisfaction (IHI, n.d.-b). This framework guided 
the project, by focusing on making changes that could be implemented to solve deficiencies in 
INCREASING MEDICATION ADHERENCE  28 
healthcare practices and improve the quality of care delivered to patients. Using the Health 
Belief Model and the IHI Model for Improvement together aimed to produce both patient-
centered and systems-level changes to improve medication adherence at the project site. 
Ethical Consideration & Protection of Human Subjects  
Ethical considerations and protection of human subjects include consideration of patient 
harm, safety, equality, equity, and the use of protected health information. Ethical principles in 
research and quality improvement included respect for persons, beneficence, and justice (Adashi 
et al., 2018). Respect for persons is paramount and encompasses a wide array of principles such 
as informed consent, autonomy, and personal dignity, all of which should be protected and 
ensured (Dearman et al., 2020). Beneficence is benefitting the individual while reducing harm to 
the extent possible. An assessment or risks and benefits weighs the potential benefits with all 
potential harms when making decisions. Justice is the process of equal and equitable treatment 
for all individuals. These three principles guided the Doctor of Nursing Practice (DNP) project 
development. The project provided education to the physicians and advanced practice providers 
to improve medication adherence in patients and entailed implementing patient-centered 
interventions that pursued concordance with patients’ expectations. This project aimed to respect 
all persons by providing patient dignity and autonomy through participation in shared decision-
making. It is beneficent by providing benefits to the patient in meaningful ways without causing 
any undue harm. Finally, it exercised justice by designing an appropriate, inclusive, and 
equitable project. 
 As patients were the ultimate beneficiaries of this DNP project, all recommended and 
required ethical processes, protocols, and guidelines were followed. First, an Academic Integrity 
Pledge was signed by the project lead to ensure academic integrity and uphold the university's 
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standards. Second, organizational approval to partner with the practice and conduct the DNP 
project at the project site was obtained. Third, ethical education was attained by the project lead 
before the initiation of the project. Successful completion of the Collaborative Institutional 
Training Initiative (CITI) program for research, ethics, and compliance training was required by 
the university. The CITI Program (2016) provides educational courses and materials designed to 
provide ethical education to investigators, staff, and students. The courses provided education 
concerning ethical guidelines and principles for protecting human subjects, vulnerable 
populations, legal considerations, and institutional review board processes. The content of these 
modules contributed to the project lead’s ethical foundation.  
Lastly, this DNP project was reviewed for compliance with institutional review board 
standards. Reviews are intended as an independent appraisal of the project’s impact to ensure 
that human subjects are protected (CITI Program, 2016). The project site itself did not require 
IRB approval or have an informal project approval process. The university required completion 
of a Quality IRB Self-Certification Review to determine whether an institutional review board 
required a formal review. Upon faculty approval, the review included a brief description of the 
project and a declaration of the project’s intent and was submitted via Qualtrics to the 
university’s IRB. After the review process, it was determined that the project did not meet the 
requirements for human subject research and required no further review by the institutional 
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Section III. Project Design 
Project Site and Population  
 The project site was a family practice office located in a rural county of central North 
Carolina. It was a Rural Health Clinic, designated by the Centers for Medicare and Medicaid 
Services (CMS) to improve healthcare access (Medicare Learning Network, 2019). Rural Health 
Clinic status was granted due to their location in a rural, underserved area with a health-
professional shortage. As required by the designation, the practice used team-based care with at 
least 50% of provider staffing time consisting of nonphysician providers, including nurse 
practitioners, physician assistants, certified nurse-midwives, clinical psychologists, or clinical 
social workers. The project site met these qualifications with three physicians and 16 advanced 
practice providers. 
Description of the Setting 
 The project site setting was a large private, for-profit primary care office. According to 
the organization’s website, their mission was medical excellence, their values included service, 
compassion, knowledge, and safety, and their vision was to help their patients and their 
community achieve their health goals ([Clinic Site], n.d.). The office location was in a rural 
central North Carolina county, and served three additional surrounding counties. The office 
served approximately 25,000 active patients and was the most extensive private practice in the 
area. The practice had a diverse payor mix and accepted nearly all insurance plans, including 
private insurance and Medicare and Medicaid. Their patients ranged from newborn through the 
end of life, and they provided a full range of family medicine services, including primary care, 
pediatrics, obstetrics and gynecology, chronic disease management, geriatrics, and long-term 
care.  
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The project site was embedded within an economically distressed county with a Tier 1 
ranking in North Carolina (North Carolina Department of Commerce, 2019). Tier 1 is the lowest 
rating, indicating it was one of the most disadvantaged counties based on the unemployment rate, 
household income, property tax per capita, and population growth. According to the North 
Carolina Institute of Medicine (2019), the project site’s county was home to around 40,000 
individuals. Of these, 16% were uninsured adults, 24% were living in poverty, 42% were 
enrolled in Medicaid or the Children’s Health Insurance Program, and 18% were enrolled in 
Medicare. Additionally, 13% did not have access to a vehicle, and 21% were current smokers 
(North Carolina Institute of Medicine, 2019). 
Description of the Population 
 The project population comprised three physicians, one family nurse practitioner, 15 
physician assistants, and many assistive personnel, including licensed practical nurses, certified 
nursing assistants, medical techs, and several front office personnel. The physicians specialized 
in family medicine and were board-certified through the American Board of Family Medicine. 
All physicians had more than 10 years of experience, with one having more than 30 years. The 
advanced practice providers ranged from newly graduated to more than 30 years of experience.  
Project Team 
 The project team was comprised of four individuals with direct input on the project. The 
group consisted of the project lead, the site champion, the medical director, and the university 
clinical faculty advisor. The project lead was a baccalaureate-prepared registered nurse with 
seven years of experience with concentrations in women and infants’ health and emergency 
medicine. She was responsible for planning, implementing, evaluating, and disseminating the 
Doctor of Nursing Practice project.  
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The second member of the project team was the site champion. She was a physician 
assistant with more than 10 years of experience. She was the only staff member in the office 
whose time was dedicated to quality metrics. Her contributions to the project included serving as 
an intermediary between the project lead and the project site, project facilitation, advice, and 
direction. The third member of the project team was the medical director. He was a family 
practice physician with more than 30 years of experience and the project’s sponsor. His 
responsibilities included approving the project, facilitating implementation, scheduling staff 
meetings, office management, and serving as the medical, organizational, and financial decision-
maker. The fourth team member was the project lead’s clinical faculty member from the 
university. She was a PhD and registered nurse at a major medical center for more than 30 years, 
had a Nurse Executive Board Certification, and had many publications to her credit. Her 
responsibility in the project was to offer guidance, support, and leadership to the project lead. 
Project Goals and Outcome Measures 
 The project’s primary goal was to increase medication adherence in patients with 
Medicare taking statins, oral antidiabetics, and renin-angiotensin system antagonists in Medicare 
patients at the project site by April 2021. The secondary goal was to improve the project site’s 
individual star ratings for the three quality measures related to medication adherence from Blue 
Cross Blue Shield (BCBS). This project evaluated both outcome and process measures. The 
individual star ratings for medication adherence to statins, oral antidiabetics, and renin-
angiotensin system antagonists from BCBS were the outcome measures for the project. The 
process measures were related to the project’s interventions which included assessing patients’ 
medication adherence, changing prescription practices, educating patients about regular follow-
up, and recapturing patients identified as nonadherent. 
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Description of the Methods and Measurements 
The project desired to impact the project site’s average star rating through the individual 
medication adherence quality measures. Outcome measures directly impact the goal, relate to an 
individual’s health status, and are considered the primary drivers (Agency for Healthcare 
Research and Quality [AHRQ], 2015). Therefore, the individual star ratings were the primary 
drivers and the outcome measures used to evaluate the project’s impact (see Appendix C). The 
outcome measures included the three individual star ratings for medication adherence to statins, 
oral antidiabetics, and renin-angiotensin system antagonists for BCBS. The required levels to 
reach a 5-star rating for BCBS were 86.5% for statins, 84.5% for oral antidiabetics, and 87.5% 
for renin-angiotensin system antagonists (site champion, personal communication, October 12, 
2020).  
There were six process measures used to evaluate the project’s impact on standardizing 
the process for medication adherence. Process measures are indirectly related to the goal, related 
to healthcare delivery, and associated with the secondary drivers (AHRQ, 2015). There were four 
secondary drivers, including assessing patients for medication nonadherence, improving 
prescription-writing practices, identifying patients with low health literacy, and recapturing at-
risk patients. The first driver was patient assessment. There were two process measures related to 
this driver. Identifying patients who were nonadherent was to allow providers the opportunity to 
intervene while the patient was present in the office. The providers were encouraged to chart a 
Current Procedural Terminology (CPT) code or a code for the 10th revision of the International 
Statistical Classification of Diseases and Related Health Problems (ICD-10) for medication 
nonadherence if applicable. Also, the number of Domains of Subjective Extent of Nonadherence 
(DOSE-Nonadherence) measures in eligible patient charts each week was tracked. This scale 
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measured nonadherence by asking three questions about the frequency of missed medication 
doses and then asked the patient to rate the reasons for the missed doses. Therefore, the two 
process measures related to assessment were the number and percent of visit notes with the 
presence of a procedure or diagnosis code and the number and percent of charts with the 
presence of a DOSE-Nonadherence form. 
The second secondary driver was prescription writing practices. Kaiser Permanente 
(2016) reported doubling the likelihood of medication adherence in patients by changing 
prescription practices that are more patient friendly. These included writing prescriptions for 90 
days or more whenever possible, sending them to a mail-order pharmacy, and prescribing 
medications that cost less than $10. Thus, two of these were selected as process measures to 
determine changes in prescription writing habits. The number and percent of prescriptions 
written for 90 days or more and the number and percent of prescriptions sent to mail-order 
pharmacies was tracked. 
The third secondary driver was the patient’s lack of understanding or education about the 
need for regular follow-up visits for medication adherence. The process measure for patients’ 
awareness of the need to obtain regular follow-up was measured by the number and percent of 
patients who scheduled a follow-up appointment during their visit. This process measure reflects 
the patients’ understanding of the importance of regular follow-up and when they need to return.  
The fourth secondary driver was recapturing individuals who were already nonadherent 
to their medication. The nonadherent patients were identified and an alert was placed into their 
chart so providers would be able to assess the patient when they came in to be seen. 
Additionally, if patients had not been seen in the last three months, they were called to return to 
the clinic for a medication adherence evaluation. The two process measures included the number 
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of patients needing to be recaptured and the number and percentage of how many did not have a 
scheduled follow-up appointment. These process measures were chosen as the number of 
individuals flagged every month were expected to decrease over time if the issue was addressed 
through interventions to reduce individuals’ barriers.  
A Plan-Do-Study-Act (PDSA) tool was employed to evaluate the project’s progress. A 
PDSA form (see Appendix D) was adapted from the Institute of Healthcare Improvement’s 
Model for Improvement and the PDSA Worksheet for Testing Change from the Minnesota 
Stroke Program (Langley et al., 2009; McQuillan et al., 2016; Minnesota Stroke Program, 2017). 
The form was utilized to document and monitor changes, identify areas of concern, guide the 
process steps, and document progress with implementation. The review was completed monthly. 
Results guided modifications and changes to implementation as needed to improve the new 
process. Feedback and updates were presented by the project lead monthly at the staff meetings.  
Lastly, a run chart was employed to display the data results. Run charts are beneficial for 
assessing effectiveness over time (IHI, n.d.-c). They have three benefits when displaying data: 
demonstrating whether a process is working well or not, determining if a change has occurred, 
and displaying the change’s value. The run chart was useful for evaluating whether improvement 
had occurred as it demonstrated patterns over time.  
Data Collection Process 
The project lead collected data on an Excel spreadsheet from three sources: the electronic 
health record, a progress report from BCBS, and an online app from an affordable care 
organization that partners with the project site. These sources were used to obtain demographic 
data and data for the outcome and process measures. All reports and data were saved to a shared 
folder stored on the project site’s secured server and could only be accessed through a designated 
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login created for the project lead. A virtual private network was installed on the project lead’s 
computer for access to the server, which was protected by a secure login and password that only 
the project lead and the office manager knew. No information could be accessed, copied, saved, 
or printed outside the project site’s server. 
The progress report from BCBS provided the star ratings for medication adherence to 
statins, oral antidiabetics, and renin-angiotensin system antagonists. The star ratings data were 
entered into a Star Rating Data Tool (see Appendix E). The online app provided a list of patients 
who were nonadherent to their medications from participating insurers. The nonadherent 
patients’ data were collected on a Recaptured Report Data Tool (see Appendix F).  
The electronic health record was used to gather data pertaining to the patients’ visits. The 
site champion ran three reports from the electronic health record, one each for the weekly visits 
for patients taking statins, oral antidiabetics, and renin-angiotensin system antagonists. Chart 
reviews were conducted, and the data were entered into a Data Collection Tool (see Appendix 
G). The three electronic health record reports were limited to adult patients who were seen the 
week prior for patients taking statins, oral antidiabetics, and renin-angiotensin system 
antagonists.  
Data collected included demographic data, prescriber-related data, and patient-recapture 
data. Demographic data included information related to the patient’s race and ethnicity, sex, age, 
and insurance type. The race and ethnicity category consisted of the number and frequency of 
individuals who were Black, White, Hispanic, or other. The sex category included the number 
and frequency of individuals who were male or female. The age ranges consisted of the number 
and frequency of individuals who reported their age between 18-44 years, 45-64 years, or 65 
years and older. The insurance type included the number and frequency of individuals who 
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reported their health insurance company as BCBS, Medicare, Medicaid, UnitedHealthcare, or 
other.  
Prescriber-related information included the data related to the medication adherence 
assessment and billing codes present, prescriber prescription practices, pharmacy usage, and 
follow-up scheduling. Medication adherence assessment consisted of the number and frequency 
of uses of the DOSE-Nonadherence measure and the presence of diagnosis or procedure codes in 
the chart. Prescription practices include the number and frequency of prescriptions written for 90 
days or more. Pharmacy usage included the number and frequency of prescriptions sent to mail-
order pharmacies. Follow-up scheduling included the number and frequency of patients who 
scheduled a follow-up visit within six months at the time of their office visit.  
Patient recapture data was related to the patients reported as nonadherent by the 
accountable care organization. The data included the total number of patients who are 
nonadherent and the percent who had a follow up visit scheduled within six months. No 
protected health information was collected. 
Descriptive statistics were used to describe the data from the project results. Descriptive 
statistics allowed the data to be condensed and simplified into a summary and presented in a 
meaningful form (Kaur et al., 2018). Descriptive statistics formed the basis for comparing and 
displaying data to effectively measure the outcomes. They were used for analysis and reporting 
the results, which were presented to make it easier to see how the data reflected the quality 
improvement initiative (Mason, 2019). The descriptive statistics included the total number, 
frequencies, and percentages. 
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Implementation Plan 
Implementation occurred in three parts. The first part included education for providers 
and nursing and office staff on the new process. The provider education consisted of five 
handouts targeting medication adherence supplied by the accountable care organization and a 15-
minute PowerPoint presentation outlining the four needed actions by the providers: assessment 
for medication adherence, improved prescription practices, increased education about follow-up, 
and patient recapturing.  
The first action was assessment for medication adherence, which was conducted along 
with the use of the DOSE-Nonadherence measure. The tool was distributed with the 
demographic forms at check-in to patients with Medicare. It was stressed that if a provider 
identified medication nonadherence during the screening, an effort should be made to identify 
and overcome the patients' barriers. To encourage medication adherence screenings, educational 
posters were hung in all exam rooms that targeted medication adherence for patients, staff, and 
providers. Second, providers were encouraged to write prescriptions for 90 days or longer when 
possible, to send prescriptions to a mail-order pharmacy, and to prescribe medications with low 
copays. Third, providers were asked to increase education to patients, reminding them of the 
need for close follow-up, and request their patients make a follow-up appointment during the 
visit. Fourth, to recapture nonadherent patients, alerts were placed on the identified patients’ 
charts and those who did not have a scheduled follow-up appointment were called to schedule 
one if possible. The alert was intended to inform the provider of the patients’ nonadherent status, 
remind the providers to assess for medication adherence, and encourage them to identify and 
treat contributing barriers. Nursing staff education reinforced existing rooming procedures, 
including completing the medication review thoroughly during the intake process with the 
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history collection. Instructions were provided to the staff and patients to keep the DOSE-
Nonadherence form in the room to discuss with the provider. 
 Following the education, the second part was implemented as the providers began to use 
the new process to address medication adherence with patients. The providers were encouraged 
to address medication adherence in all patients and use barrier reduction strategies. Together, the 
provider and patient were to review the assessment form and develop a plan to achieve 
medication adherence. The provider’s recommended treatment was encouraged to be acceptable 
to the patient and within their ability (Bosworth et al., 2016; Voshaar et al., 2015). If the provider 
assessed medication adherence, they were encouraged to enter a procedure or diagnosis code into 
the chart, if applicable.  
The third part included using the app provided by the accountable care organization. This 
app functioned as a database of patients who were nonadherent and needed intervention. A 
reminder was placed on the electronic health record for all patients flagged as nonadherent. A 
provider reviewed each patient on the list to determine if they need to be called or have a visit 
scheduled. If the patient needed a follow-up visit, a member of the office staff contacted the 
patient to request they schedule an office visit. The providers were responsible for assessing and 
treating the patients at their next office visit.   
The project lead monitored the implementation of the new process. Monthly reviews 
were conducted using a PDSA worksheet to identify areas for improvement. The project lead and 
site champion gave small PowerPoint presentations with status updates at staff meetings 
monthly. Staff and providers were encouraged to report successes, barriers, and concerns to the 
project lead for attention and resolution. 
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Timeline 
A timeline was developed for the project outlining the beginning and end dates and other 
important dates and events to organize and manage the project (see Appendix H). The project 
lead obtained organizational approval for the project, and a site champion was identified. A 
literature review of best practices was conducted. Meetings between the project lead and site 
champion began biweekly and transitioned to weekly as the project developed and was 
implemented. Educational sessions for providers and nursing staff occurred at a staff meeting on 
January 6, 2021. Data collection began on January 12, 2021. Thereafter, weekly reports were 
collected each Tuesday during the weekly meetings. Data collection continued until Week 16 on 
April 27, 2021. Weekdays for the project lead to be onsite were Tuesdays. Data analysis 
occurred in May 2021. Dissemination of the findings were completed at the project site and 
university in July 2021.   
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Section IV. Results and Findings 
 Results from this project included demographic, quantitative, and qualitative findings. 
Demographic and quantitative results were derived from three key areas: star ratings, recapture 
patients, and office visits. Star ratings and the data on recapture patients was collected monthly 
for four months in 2021, from January through April. The data collected from chart reviews on 
office visits occurred during 16 consecutive weeks in 2021, from January through April, and 
included patients with Medicare who were taking statins, antidiabetics, and renin-angiotensin 
system antagonists. Qualitative results were derived from the plan-do-study-act (PDSA) cycle 
reviews used to evaluate project progress. These reviews were completed at monthly intervals in 
February, March, and April. 
Results 
Star Ratings 
 For the project site, the star ratings decreased for statins, improved for oral antidiabetics, 
and were unchanged for the renin-angiotensin system antagonists. The project site’s ratings from 
Blue Cross Blue Shield (BCBS) for statins was 3 stars in December and remained stable before 
decreasing in March with 3, 3, 2, and 2 stars for January, February, March, and April, 
respectively. The ratings showed a marked improvement for oral antidiabetics, which were at 2 
stars in December before increasing to 4, 4, 5, and 5 stars for January through April. Ratings for 
renin-angiotensin antagonists were 3 stars in December and remained stable in January before 
decreasing and then recovering with ratings of 3, 2, 3, and 3 stars for January through April.  
Recapture Patients 
 During the project period, there were 517 patients who were identified as nonadherent to 
one or more medications and needed to be recaptured. Of these patients, 44% (245) were 65 
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years and older, 44% (232) were 45-64 years, and 7% (39) were 18-44 years. A majority of the 
patients were female at 53% (273) compared with 47% (244) males. Of the 517 patients, 47% 
(243) were Black, 45% (232) were White, 5% (24) noted other, and 4% (18) were Hispanic. 
Health insurers for the recaptured patient data include 84% (434) for BCBS, 12% (62) for 
UnitedHealthcare, 3% (14) for Medicare, and 1% (7) for other private insurers. 
In total, there were 613 prescriptions that were past due to be filled among the 517 
patients, averaging 1.19 prescriptions per patient. Of these prescriptions, 36% (222) were renin-
angiotensin system antagonists, 34% (204) were statins, and 31% (187) were non-insulin 
antidiabetics. Of the total nonadherent patients, 69% (346) did not have a follow-up visit 
scheduled. Outreach was completed for 50% (269) of the patients while the other 50% (248) 
were unable to be contacted.  
Patient Visits 
 During the project period, there were 2624 patients’ charts reviewed from patient visits. 
Demographic analysis (see Appendix I) showed most patients were female, at 64% (1696) 
compared with just 36% (928) male (see Figure I1). Of the patients, 71% (1870) were 65 years 
of age and older, 26% (656) were 45-64 years, and 4% (96) were 18-44 years (see Figure I2). 
Further, a significant majority were Black, at 57% (1493), while 40% (1039) were White, 4% 
(92) noted other, and 2% (42) were Hispanic (see Figure I3). For the patient visits, 53% (1343) 
had Medicare alone, while 47% (1269) had additional coverage with 17% (449) with BCBS, 
15% (405) with UnitedHealthcare, and 15% (415) with other private insurers (see Figure I4). 
 Process measure analysis (see Appendix J) showed, of the 2624 total patients’ charts 
reviewed, only 6% (167) had a DOSE-Nonadherence form completed, and 3% had a diagnosis or 
procedure code documented that related to medication adherence. There were 622 total 
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prescriptions written for statins, antidiabetics, and hypertensives. Of the prescriptions, 85% (526) 
were written for 90 days or more, and 12% (73) were sent to a mail-order pharmacy. On average, 
62% (1639) of patients scheduled a follow-up visit prior to leaving the office. 
 Further review was conducted to evaluate for statins, non-insulin antidiabetics, and renin-
angiotensin system antagonists individually. Of the 2624 patients, 43% (1133) were on statins, 
32% (828) were on antidiabetics, and 656 (25%) were on antihypertensives. Of the 1133 patients 
on statins, 6% (74) had a DOSE-Nonadherence form completed, 3% (34) had an ICD-10 or CPT 
code documented, 92% (240) had prescriptions written for 90 days or greater, 11% (29) of the 
prescriptions were sent to a mail-order pharmacy, and 59% (660) had a scheduled follow-up 
visit. Of the 828 patients on antidiabetics, 5% (46) had a DOSE-Nonadherence form completed, 
4% (34) had an ICD-10 or CPT code documented, 75% (139) had prescriptions written for 90 
days or greater, 11% (22) of prescriptions were sent to a mail-order pharmacy, and 64% (533) 
had a scheduled follow-up visit. Of the 656 patients on antihypertensives, 6% (45) had a DOSE-
Nonadherence form completed, 4% (23) had an ICD-10 or CPT code documented, 86% (151) of 
prescriptions were written for 90 days or greater, 11% (19) of prescriptions were sent to a mail-
order pharmacy, and 62% (405) had a scheduled follow-up visit. 
PDSA Cycle Review 
In total, there were four cycle reviews completed at monthly intervals. Five themes were 
identified relating to the project processes: difficulty running reports, challenges with the DOSE-
Nonadherence form distribution, provider acceptance of assessment for medication adherence, 
placing alerts on patients’ charts, and follow-up visits. It was quickly identified that the planned 
reports from patient visits did not target the intended patients and required chart reviews to find 
those who had been prescribed a prescription for a statin, a non-insulin antidiabetic, or a renin-
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angiotensin system antagonist. Secondly, difficulties in instituting the DOSE-Nonadherence 
form into the workflow were noted. In all four reviews, the struggle with distribution and the 
eventual staff abandonment of the process were identified. However, there were also positive 
results related to the nonadherence forms. For example, some providers annotated on the forms 
and in the patients’ charts, which showed that the forms were being used to assess medication 
adherence. 
Another result was the documentation of providers’ assessment for medication 
nonadherence with patients. Evidence of assessment occurred even when the nonadherence 
forms, meant to trigger the conversation, were not present during the visit. Many providers 
accepted and embraced the need for initiation of conversations about medication adherence with 
patients. Another significant result was the receptiveness to alerts related to medication 
nonadherence on patients’ charts. Some providers wrote notes in the alert to communicate with 
the project lead, though some alerts were deleted without annotating barrier identification or 
interventions. Lastly, patients who needed to be recaptured were contacted by office staff to 
schedule an appointment to assess medication nonadherence if they did not have one scheduled 
within three months. 
Committee for Quality Metrics and Incentives 
 An essential result of the impact of this project at the project site was the creation of the 
Committee for Quality Metrics and Incentives (CQMI) by the site champion. The project lead 
was, in part, a catalyst for the creation of the committee. Due to the initiation of the project and 
the project site’s desire for improved quality metrics, star ratings, and transition to value-based 
care, the medical director allocated more resources to these goals. Prior to inception of this 
project, the only time devoted to quality improvement was four hours a week from the site 
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champion. After concluding the project, the committee had expanded to two providers who were 
dedicating time during the week, two full-time support staff members, and the project lead.  
Discussion of Major Findings 
Star Ratings 
The star ratings from BCBS were variable throughout the project for statins, 
antidiabetics, and antihypertensives. The individual medication adherence scores were calculated 
over a rolling 12-month calendar and were based on claims data, which can take months to clear, 
so it was difficult to know if the scores were truly reflective of the project's efforts, which 
spanned the first 16 weeks of the year. The star ratings may need a longer duration to show the 
effects accurately. The results from the process measures of the project demonstrated that the 
project was successful: principally, the increase in 90-day prescription writing. Therefore, the 
project lead anticipated this would translate into improved star ratings in the future months. This 
prediction is based on the research from Kaiser Permanente that reported writing 90-day 
prescriptions increased the likelihood almost two-fold of achieving higher star ratings 
(Schmittdiel et al., 2015).  
Recapture Patients 
 Monitoring patients through the accountable care organization's online app allowed for 
easy identification and targeted interventions to individuals who were already nonadherent to at 
least one medication. However, collecting this data every month was possibly too frequent since 
patients refill their prescriptions approximately every three months if 90-day supplies are used, 
as recommended. Depending on the percentage of their medication refills (goal is 80%), the 
patient may need to refill medications one or more times to become adherent. The patient 
remains on the list until they fill their prescriptions enough to catch up. Therefore, depending on 
INCREASING MEDICATION ADHERENCE  46 
the number of medications and fill percentage the patient is at, they may stay on the list for 
months. The alerts placed on the accounts of the nonadherent individuals in the electronic health 
record worked well to signal the patients’ nonadherence status to providers and included the 
medication(s) that were delinquent.  
Patient Visits 
 Demographic data from the patient visits were remarkable. During the project, the 
majority of patients with Medicare that were prescribed a statin, non-insulin antidiabetic, or 
renin-angiotensin system antagonist at the project site were Black (57%) versus White (40%). 
The census data from 2019 shows the state averages in North Carolina are 22% African 
Americans and 71% White, whereas the project site’s county is 51% African American and 39% 
White (North Carolina Institute of Medicine [NCIOM], 2019). Additionally, there were twice as 
many females, which accounted for 64% of the patients. Predictably, older adults were the 
majority of the patients with Medicare, as 71% were 65 years or older, however, that left 29%, or 
almost three in every ten, Medicare patients younger than 65 years old. Also, approximately 53% 
of all the patients had only regular Medicare, without an Advantage plan or other co-insurance. 
These demographics are essential to understanding the individual, social, cultural, and economic 
contexts of the patients touched by this project, and further points to the need for system-level 
changes along with targeted interventions. In the past, medication adherence has been viewed as 
the patient’s responsibility. However, evidence overwhelmingly suggests the need for engaging 
healthcare team members to embrace provider changes along with patient-centered, effective 
interventions to improve clinical outcomes while reducing costs (Kim et al., 2018; Neiman et al., 
2017).  
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Evidence from the review demonstrated the providers were beginning to incorporate 
assessment for medication adherence into their patient visits, even when the defined process was 
not followed. For example, the project lead found notes written on completed nonadherence 
forms, written in the alerts placed on the charts, and annotated in the history of present illness 
and assessment and plan portions of the providers’ notes. The evidence promoted providers’ 
responsibility to assess medication adherence and create patient-centered interventions that 
address individual’s barriers to increase medication adherence (Costa et al., 2015). The 
providers’ noticeable efforts demonstrated engagement and will likely improve medication 
adherence of their patients. 
When evaluating the data, the first four weeks were used as the baseline to evaluate for 
improvement and were the basis for calculating the trend’s direction (see Appendix J). Three of 
the process measures showed increased percentages with an overall increasing trend for the total 
of all patient visits. The percentage of 90-day prescriptions increased from about 80% to 85% 
(see Figure J1). The percentage of scheduled follow-up visits increased from about 58% to 62% 
(see Figure J2). The diagnosis and procedure code use in the chart increased from 0% to 3% (see 
Figure J3). The literature indicated writing 90-day prescriptions instead of 30-day prescriptions 
almost doubles the likelihood of the patient being adherent and is the single most significant 
predictor of adherence (Schmittdiel et al., 2015). Therefore, this process measure was considered 
the most crucial piece of the project. The only process measure that did not trend as an 
improvement by the end of the 16-week implementation period was for the Domains of 
Subjective Extent of Nonadherence (DOSE-Nonadherence) form, which likely resulted from a 
lack of distribution (see Figure J4). Despite the distribution issues, the process of assessment was 
considered a success. Additionally, when the graphs are compared together, the use of the codes 
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increased when forms were distributed, likely demonstrating the value of using a formal 
assessment tool. 
When the data for statins, antidiabetics, and antihypertensives were considered 
independently, there were mixed reviews. Of the prescriptions written, statins that were written 
for 90 days or more increased from 89% to 92% and antidiabetics increased from 66% to 75%, 
both revealing a net trend toward improvement. However, the antihypertensives’ trend decreased 
over the 16 weeks, with the percentage of 90-day prescriptions declining from 89% to 86%. 
There were eight weeks above the median line and seven weeks below it. Also, there were two 
low values at weeks 9 and 13, but both weeks had a small number of prescriptions written (nine 
and four, respectively) which may have skewed the data toward a downward trend.  
Committee for Quality Metrics and Incentives 
The Committee for Quality Metrics and Incentives (CQMI) was developed, in part, 
because of the project’s influence and the project’s site’s commitment to improving the quality 
of care. The committee was created to focus more efforts on quality initiatives at the project site, 
and, though the project lead was not an employee, she was included as a member. Due to the 
success of the project, which was the first they had participated in, the medical director stated he 
desired to host more projects at the site. Therefore, the project site and the site champion agreed 
to welcome a second Doctor of Nursing Practice student project and was planning to host 
additional projects in the future.       
  
INCREASING MEDICATION ADHERENCE  49 
Section V. Interpretation and Implications 
Costs and Resource Management 
 This project sought to decrease healthcare costs and resources while producing tangible 
benefits for patients, providers, and the project site while improving population health. 
Therefore, both the costs and benefits were evaluated. The costs related to this project included 
both direct and indirect costs. The direct costs were related to financial resources, such as money, 
provider and support staff time and labor, and supplies needed. The costs were itemized in a 
project budget (see Appendix K). The project's indirect costs included what was not done when 
the resources were directed to medication adherence. These costs included time away from other 
tasks, obligations, or projects, seeing a reduced number of patients, and the loss of provider 
productivity, ultimately affecting the number of patients seen and provider reimbursement for the 
practice. The project implementation cost was estimated at $2354.60. However, the printing 
costs were approximately $424.80, which could be eliminated simply by using an electronic 
version which would bring the total cost to less than $2000. 
 The benefits of this project were also direct and indirect. The direct benefits included 
those which affected the patient. Since medication adherence enhances health outcomes, patients 
are likely to experience reduced sequelae, a decrease in morbidity and mortality, and a reduction 
in hospital admissions and readmissions because of improved quality of care and reduction in 
medication nonadherence. Further, patients are likely to experience a higher quality of life with 
better disease control. Medication nonadherence costs billions of dollars, increases 
hospitalizations and medical visits, and contributes to the deaths of more than 100,000 patients 
annually (R. Cutler et al., 2018). Additionally, medication nonadherence adds treatment costs, 
some of which are passed on to the patients. For example, medication nonadherence in 
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cardiovascular disease, including hyperlipidemia and hypertension, adds adjusted economic costs 
of between $3347 and $19,472 per patient, per year. Diabetes adds between $2741 to $9819 
annually. Therefore, the financial and health benefits to patients are significant if even one 
patient was impacted. If the estimate of a $7 savings for every $1 spent on medication adherence 
is accurate (National Council Medical Director Institute, 2018), then the cost of this project 
would return about $17,500 in savings alone. 
 Indirect benefits include those that affect the primary care office, healthcare 
organizations, and society. Due to the focus on medication adherence and its role in 
reimbursement, there were financial incentives for improvement. For example, the primary care 
office could increase their reimbursement through higher star ratings as higher star ratings earn 
higher reimbursement and bonuses. There were other financial incentives also, such as shared 
savings programs available through accountable care organizations and increased reimbursement 
for improved quality metrics from insurance companies. With higher star ratings and quality 
care, the primary care office can negotiate better contracts and higher reimbursement with other 
organizations and insurance companies in the future. Lastly, higher star ratings would improve 
the reputation of the project site within the community and with other healthcare partners. 
Ultimately, improved population health and reduced costs benefit healthcare organizations and 
society in a myriad of ways. 
Implications of the Findings  
 This project demonstrated important implications that are pertinent to patients, nursing 
practice, and healthcare systems. The project demonstrated there is value in targeting medication 
adherence with patients. Improved awareness of assessing for medication adherence improved 
the provider-patient interaction. It further showed that initiating quality improvement projects, 
INCREASING MEDICATION ADHERENCE  51 
even if the results are not immediately seen, is an essential part of patient care and an excellent 
avenue for nurses to demonstrate leadership. This project showed the benefit of using systems-
level changes while incorporating patient-centered interventions. The project can provide a 
foundation for the importance of medication adherence quality improvement in policy and 
practice decisions.  
Implications for Patients 
 The implications for patients were related to the increase in quality of care, an improved 
patient experience, and improved population health. This project demonstrated that increasing 
the quality of care through assessment, treatment, and follow-up can influence patient outcomes. 
Increasing patient and provider awareness of medication adherence with improved medication 
management, prescription writing, barrier identification, and treatment plans should improve 
patients’ outcomes. For example, by writing prescriptions for 90 days or more, there are many 
benefits to the patients, including decreasing the number of trips to the pharmacy every year to 
four rather than twelve, no longer holding patients’ hostage to office visits to obtain needed 
medications timely, and ending penalties for follow-up visits. Due to the scope of factors that 
affect medication adherence, using a barrier identification strategy including assessment and 
treatment along with shared decision-making offers the patient-centered care that patients 
deserve while acknowledging that patients have unique health contexts. Lastly, due to the length 
of time needed to change medication adherence rates, interventions should be purposeful, 
continuous, and tailored to the patient. 
Implications for Nursing Practice 
 This project demonstrated implications for nursing practice through four domains: 
nursing leadership, advocacy, collaboration, and accountability. Nursing shares a position of 
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leadership in healthcare. This project demonstrated that nursing has an essential voice in 
improving the quality of care with quality improvement initiatives. Nursing has a responsibility 
to initiate and influence conversations in transforming healthcare related to medication 
adherence. Advanced practice nurses can use the recommended practices in this project such as 
prescribing medications for 90 days or more, utilizing a mail-order pharmacy, writing for low-
cost medications, and increasing follow-up visits for patients with chronic diseases.  
Further, this project demonstrated that nursing is an integral partner in transitioning to 
value-based care, improving population health, and improving patient care. Advocacy is a basic 
tenet of nursing, and this project demonstrated that nurses can advocate for improved quality of 
care. Further, this project demonstrated the value of collaboration among interprofessional and 
interdisciplinary teams and showed that nursing is a valuable healthcare team member. Lastly, 
this project demonstrated nursing accountability by meeting the Essentials of Doctoral Education 
for Advanced Nursing Practice (American Association of Colleges of Nursing, 2006). 
Impact for Healthcare System(s) 
 This project demonstrated an impact on healthcare systems through various areas, 
including costs and reimbursement, quality improvement and quality metrics, improved 
population health, and culture shifts. The costs associated with healthcare are a national concern. 
This project showed the value of investing in interventions toward healthcare quality metrics 
through quality improvement initiatives related to medication adherence in a rural primary care 
office. There were many financial benefits to the healthcare system, and this project 
demonstrated that even small changes could reap significant rewards. By focusing on quality 
improvement and quality metrics, this project showed that the quality of care is enhanced, 
thereby improving the healthcare system. Patients are more than a number, and this project 
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demonstrated that systems-level interventions could be combined with patient-centered 
interventions to provide excellent care to patients. 
This project revealed culture shifts might be challenging but are necessary to transform 
care in the transition to value-based care. The change from problem-oriented visits to preventive 
care is a significant change for healthcare. By focusing on medication adherence and improving 
the quality of care, this project provided opportunities to change provider practices and priorities 
through evidence-based interventions. It demonstrated that change is possible when disciplines 
work together toward improving complex healthcare issues, such as with medication adherence. 
Further, it demonstrated the power of interdisciplinary teams in organizing and orchestrating 
changes to improve the health of a population.  
Sustainability 
 One objective of this project was the ability to continue it in the future after its formal 
conclusion. Because of the project site’s continued focus on medication adherence, transition to 
value-based care, and desire to earn higher star ratings, medication adherence remains a priority 
for the project site. Due to the project's success, its low cost to continue, and the potential for 
increased reimbursement, the project site intends to continue the project implementation with 
two changes. First, the DOSE-Nonadherence form license expires with the conclusion of the 
project. The project demonstrated the need for assessment, but there were many difficulties with 
the form and distribution never achieved desired levels. For these reasons, the project site intends 
to pursue a shortened assessment tool that can be incorporated into the electronic health record. 
A shortened form to assess medication nonadherence is available from one of the accountable 
care organizations with whom they partner. An electronic version will negate the need for the 
paper form entirely, provide an assessment tool for providers available at the time of the visit 
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with the patient, and will be automatically attached to the patient’s visit. Secondly, the number of 
chart reviews will be significantly decreased. The project site intends to request a reporting 
function from the electronic health record administrators so that reports can be generated by 
specific medication classes. Improved reports are expected to narrow the pool and decrease the 
number of chart reviews necessary to track the outcomes. Other than these two changes, the 
project site plans to continue to use the interventions from the project to focus on medication 
adherence and increasing star ratings. Additionally, the project site will continue the Committee 
for Quality Metrics and Improvement and plan and continue working on quality metrics to 
improve the quality of care. 
Dissemination Plan 
 Dissemination of the project included two presentations and submission of the project 
paper to the university’s online scholarly repository. The first presentation was at the project site 
and occurred on July 7, 2021. This presentation presented the findings and results to the 
providers and office staff at the project site, provided closure for the project, and transitioned the 
continued presence of the project elements. Second, a poster presentation with question-and-
answer session occurred at the project lead’s university on July 13, 2021. The presentation 
summarized the entire project for faculty, staff, and fellow students. Lastly, the project paper was 
submitted online to the digital scholarship repository through the project lead’s university on 
July 22, 2021.  
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Section VI. Conclusion 
Limitations and Facilitators 
Limitations 
 Several limitations were identified during the project implementation related to project 
site challenges, staffing, nonadherence form distribution, data collection, and reimbursement. 
Site challenges were related to the COVID pandemic that occurred concurrently with the project 
development and implementation. At the time of implementation, the project site became the 
only private practice in the area to begin distributing the COVID vaccine, which necessitated a 
considerable shift in resources and caused a significant need for rapid staff expansion, training, 
and rotation. Staffing changes were a substantial factor in the failure to facilitate Domains of 
Subjective Extent of Nonadherence (DOSE-Nonadherence) measure form distribution. However, 
there were other challenges with the form which affected the project. The original form did not 
include an area for the patient to write identifying data such as name and birthdate, so some 
forms could not be identified. Also, the forms were lengthy and double-sided, which took up a 
significant amount of time to complete. Some forms were not left in the room for the provider, so 
they were not available at the time of the visit. Other forms were returned partially completed, 
and some were completed incorrectly. Lastly, the project site is paperless and discourages paper 
use to conserve resources. 
 Data collection was another significant challenge. Several changes occurred during the 
implementation phase affecting the data for the recapture patients. There was a planned 
consolidation of patients from several insurance companies into the accountable care 
organization’s app. However, the planned merger was not completed as initially scheduled, nor 
was it completed during the project, skewing the patients to a vast majority of Blue Cross Blue 
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Shield patients while neglecting patients with other insurance companies.  It was quickly 
identified that the reports used for chart reviews were not specific enough to pull patients who 
had been prescribed medications from the specified drug classes only during the past week. 
Instead, they pulled visits for all the patients seen during the past week who had ever received a 
prescription for the specified drug classes. This necessitated a significant number of chart 
reviews, more than 200 charts weekly, to identify the charts with new and refilled prescription 
medications for the specified drug classes. The number of chart reviews took a significant 
amount of time, delaying timely adjustments, frequently by one to two weeks. During the fifth 
week, the reports were generated incorrectly, including only patients with regular Medicare, 
possibly skewing the data results. Lastly, the plan-do-study-act (PDSA) cycle reviews were 
conducted monthly, which was too infrequent in the beginning to correct the course and address 
the challenges encountered. 
 Challenges regarding reimbursement were related to the star ratings, providers’ transition 
to value-based care, quality metrics changes, and a lack of reimbursement for coding for 
medication adherence. Due to the calculation process for the star ratings, a change may not be 
noted for a significant amount of time as the data still includes performance from last year. 
Despite the significant impact medication adherence has on star ratings, there is no 
reimbursement available for coding for it in the chart. Lastly, at the project site, there was a 
prevalent belief that providers do not influence medication adherence rates because the data is 
obtained from claims data. These contributed to the challenge in transitioning to value-based care 
by the providers and may have contributed to providers viewing medication adherence as a low 
priority during the visit and contributed to a lack of charted codes. 
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Facilitators 
 Many facilitators contributed to the success of the project implementation and were 
related to project site, provider and staffing support, and research and data availability. Site 
facilitators included the concurrent roll-out of the COVID vaccines and the novelty of addressing 
medication adherence. While the vaccine roll-out created challenges related to staffing, it also 
provided an opportunity to increase visits for Medicare patients due to vaccine initiation, which 
began with the older adult population. The project site’s interest in addressing medication 
adherence was triggered by the project site’s desire to improve quality metrics and star ratings, 
particularly related to medication adherence. This mutual focus on quality metrics and star 
ratings drove stakeholder support for the project’s interventions and were without opposition, 
which encouraged providers at the project site to actively participate in the project. The chart 
reviews often showed that the providers were assessing for medication adherence even when 
there were no DOSE-Nonadherence forms or codes noted in the chart. 
Provider and staffing support was an invaluable contribution. The medical director was 
supportive, facilitated a partnership between the project lead and the site champion, and allocated 
space at the project site for the project lead to work. Additionally, the other providers and staff at 
the project site integrated the project lead into the organization and offered comments, feedback, 
and suggestions for the project. The project site’s investment of additional staff and resources 
into quality improvement, specifically through the Committee for Quality Metrics and Incentives 
(CQMI), provided staff and resources for the project’s tasks when needed. The project lead was 
considered a committee member and invited to attend all meetings and discuss project progress. 
The research related to medication adherence was plentiful, offering the project lead a 
wealth of evidence-based information on the subject. The project was supported by evidence-
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based research and was reasonable, feasible, and relevant to the project site and its population. 
Data was plentiful and made available through the site champion. Lastly, the PDSA cycle 
reviews were an asset in evaluating the project’s processes, with the format lending itself well for 
communication with the project site at the staff meetings. The providers offered feedback that 
the updates helped them remember the project and keep the recommendations in mind. 
Recommendations for Others 
 The recommendations that resulted from this project pertain to three areas: replication, 
value-based care, and quality improvement initiatives. For replication, the project lead 
recommends using an electronic medical record-based assessment tool that is immediately 
available to providers and is automatically included in the patient’s chart. Also, it is 
recommended to find an improved method for identifying charts with prescriptions written 
during the visit, not just patients with the specified medication classes. This will reduce the 
number of chart reviews needed to track progress. It is further recommended to invest in value-
based care and address medication adherence in a population. This project serves as a foundation 
for addressing medication adherence, but there is still work to be done to create sustainable 
change. The project lead recommends starting conversations about medication adherence, using 
a few simple questions, and then targeting nonadherence through barrier reduction interventions. 
For quality improvement projects, it is recommended to use collaboration and interdisciplinary 
teams to find ways to improve the quality of care for populations. Specifically, primary care 
offices could consider appointing a site champion and investing in projects to facilitate improved 
quality of care, further the reach of evidence-based research, and inspire and intensify 
stakeholder support.  
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Recommendations for Further Study 
 Recommendations for further study include the areas related to pharmacy, population 
health, increasing target populations, and research. Improving data exchange between 
pharmacies and primary care offices is an area needing further study. Aside from the data 
available from the accountable care organization, which only pertained to specific patient 
populations for the project site, there was no way to evaluate patients’ prescription fill history. 
Additionally, when prescription data was available, it did not address all the critical information 
needed to evaluate prescription fill habits. Another area that needs further study is to apply these 
lessons to managing medication adherence in younger patient populations. This project focused 
on Medicare patients, with the majority older than 65 years old at the project site. While 
medication adherence is undoubtedly recommended for these patients, initiating a medication 
adherence program that targets younger patients will likely yield better results over the lifespan. 
Final Thoughts 
 This project sought to improve the quality of care in a rural primary care office. Due to 
the weight of medication adherence on quality metrics and the effects on reimbursement, 
medication adherence to statins, oral antidiabetics, and renin-angiotensin system antagonists 
were selected for the project. A literature review was conducted to improve medication 
adherence. The Health Belief Model and Institute for Healthcare Improvement’s Model for 
Improvement were used to incorporate systems-level changes with patient-centered 
interventions.  
The project targeted medication adherence through assessment, treatment, follow-up, and 
recapturing patients who demonstrated nonadherence. The three outcome measures, the star 
ratings for medication adherence, were split, demonstrating a small decrease in statins, a 
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significant increase in oral antidiabetics, and remaining steady in antihypertensives. The first 
process measure, the DOSE-Nonadherence form, did not demonstrate increased use; however, 
the assessment aspect of the project was considered successful due to evidence of assessment for 
medication adherence. The other four process measures showed improvement with an increase in 
writing prescriptions for 90 days or more, increased mail-order pharmacy use, inclusion of 
diagnosis and procedure codes in patient charts, and increased follow-up visits. The increased 
assessment and treatment of medication adherence at the project site, along with the more 
patient-friendly prescription writing practices and increased follow-up visits are key findings that 
demonstrate the effectiveness of the project. Therefore, the project lead anticipates an increase in 
star ratings. This project provided a foundation for improved medication adherence in patients 
with Medicare and demonstrated the role of nursing leadership in improving population health.  
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Appendix D 
PDSA Worksheet for Testing Change 
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Adapt, adopt, or abandon? What is next? 
 
 
Note: Adapted from the Model for Improvement from the Institute for Healthcare Improvement 
PDSA Worksheet for Testing Change and the Minnesota Stroke Response’s PDSA Worksheet 
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Appendix E 
Star Ratings Data Tool 
 
December January February March April
Oral Antidiabetics 2 4 4 5 5
Renin-Angiotensin 
System Antagonists 3 3 2 3 3
Statins 3 3 3 2 2
BCBS Star Ratings
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Appendix F 
























Total All Categories Percentages
Recaptured Report 2021
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Appendix G 









































Total All Categories Percentages






Initiation September 16, 2020 
Site Champion identified 
 September 23, 2020 
Literature review begins 
 October 28, 2020 
Site meeting with project lead and site champion 
 November 11, 2020 
Site meeting with project lead and site champion 
 November 23 2020 
Site meeting with project lead and site champion 
 December 1, 2020 
Site meeting with project lead and site champion 
 December 15, 2020 
Site meeting with project lead and site champion 
 December 22, 2020 
Christmas break 
 December 29, 2020 
Christmas break 
 
January 5, 2021 
Site meeting with project lead and site champion 
Staff meeting January 6, 2021 - provider and staff 
training 
Week 1 January 12, 2021 Site meeting with project lead and site champion 
Baseline data collection  
Week 2 January 19, 2020 Site meeting with project lead and site champion 
Week 1 data collection 
Week 3 January 26, 2021 Site meeting with project lead and site champion 
Week 2 data collection 
Week 4 February 2, 2021 ECU Immersion week 
Week 3 data collection 
Week 5 
February 9, 2021 
Site meeting with project lead and site champion 
PDSA cycle review 1 
Staff meeting February 10, 2021 
Week 4 data collection 
Week 6 February 16, 2021 Site meeting with project lead and site champion 
Week 5 data collection 
Week 7 February 23, 2021 Site meeting with project lead and site champion 
Week 6 data collection 
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PDSA cycle review 2 
Week 8 
March 2, 2021 
Site meeting with project lead and site champion 
Week 7 data collection 
Staff meeting March 3, 2020 
Week 9 March 9, 2021 Site meeting with project lead and site champion 
Week 8 data collection 
Week 10 March 16, 2021 Site meeting with project lead and site champion 
Week 9 data collection 
Week 11 March 23, 2021 Site meeting with project lead and site champion 
Week 10 data collection 
Week 12 
March 30, 2021 
Site meeting with project lead and site champion 
Week 11 data collection 
PDSA cycle review 3 
Week 13 April 6, 2021 Site meeting with project lead and site champion 
Week 12 data collection 
Week 14 
April 13, 2021 
Site meeting with project lead and site champion 
Week 13 data collection 
Staff Meeting April 13, 2020. 
Week 15 April 20, 2021 Site meeting with project lead and site champion 
Week 14 data collection 
Week 16 
April 27, 2021 
Site meeting with project lead and site champion 
Week 15 data collection 
PDSA cycle review 4 
Complete data analysis 
 May 4, 2021 
Staff Meeting 
Dissemination July 7, 2021 
PowerPoint presentation at the project site 
Dissemination July 13, 2021 
Poster presentation at the College of Nursing 
Dissemination September 23-24, 2021 Proposed presentation at the North Carolina Nurses 















Total Age Distribution 
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Figure I3 
Total Race/Ethnicity Distribution 
 
Figure I4 
Total Medicare Plan Type Distribution 
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Appendix J 






Scheduled Follow-Up Visits 
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Figure J3 




DOSE-Nonadherence Form Distribution 
  




Item Quantity Cost Total  
Double-sided black and white copies 1000 $         0.25 $    250.00  
8.5 x 11, double-sided black and white copies laminated 20 $         2.74 $      54.80  
8.5 x 11 color single-sided, laminated 40 $       10.62 $    424.80  
    
 
Provider hours monthly 20 $       50.00 $ 1,250.00  
Staff hours monthly 20 $       15.00 $    300.00  
    
 
Staff meeting snacks (donuts and coffee) 1 $       75.00 $      75.00  
    
 
Total   $ 2,354.60 
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Appendix L 
Doctor of Nursing Practice Essentials 





Competency – Analyzes and uses 
information to develop practice 
Competency -Integrates 
knowledge from humanities and 
science into context of nursing 
Competency -Translates research 
to improve practice 
Competency -Integrates research, 
theory, and practice to develop 
new approaches toward improved 
practice and outcomes 
➢ Performed a literature review of 
medication adherence 
➢ Analyzed research to develop a plan to 
address the organizational need 
➢ Applied implementation science and 
social sciences theories by integrating 
the Institute for Healthcare 
Improvement’s (IHI) Model for 
Improvement and Health Belief Model 
as a foundation for the project  
➢ Employed PICOT method to define 
search question 
➢ Utilized library science by searching 
databases using search terms derived 
from keywords 
➢ Applied the Levels of Evidence by 
Melnyk and Fineout-Overholt (2015) 
to determine the Levels of Evidence 
for the articles discovered in the 
literature search 
➢ Analyzed and evaluated evidence-
based literature 
➢ Developed relevant, feasible, plan 
based on best available evidence that 










Competency –Develops and 
evaluates practice based on 
science and integrates policy and 
humanities 
Competency –Assumes and 
ensures accountability for quality 
care and patient safety 
Competency -Demonstrates 
critical and reflective thinking 
Competency -Advocates for 
improved quality, access, and cost 
of health care; monitors costs and 
budgets 
➢ Used the IHI Model for Improvement 
to target systems-level interventions 
and the Health Belief Model to target 
patient-centered interventions  
➢ Interacted with audiovisual materials 
to develop knowledge  
➢ Completed CITI training courses to 
strengthen ethical foundation 
➢ Completed the Quality IRB Self-
Certification Review to determine 
whether the project required a full 
review by the IRB 
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Competency -Develops and 
implements innovations 
incorporating principles of change 
Competency - Effectively 
communicates practice knowledge 
in writing and orally to improve 
quality 
Competency - Develops and 
evaluates strategies to manage 
ethical dilemmas in patient care 
and within health care delivery 
systems 
 
➢ Demonstrated accountability and 
leadership through academic 
achievement and deliverables 
➢ Attended all meetings for the 
Committee for Quality Metrics and 
Incentives  
➢ Implemented the DNP project at the 
project site 
➢ Provided leadership and 
communication through presentations 
of project findings at staff meetings  
➢ Developed a poster for the 
dissemination presentations 









Competency - Critically analyzes 
literature to determine best 
practices 
Competency - Implements 
evaluation processes to measure 
process and patient outcomes 
Competency - Designs and 
implements quality improvement 
strategies to promote safety, 
efficiency, and equitable quality 
care for patients 
Competency - Applies knowledge 
to develop practice guidelines 
Competency - Uses informatics to 
identify, analyze, and predict best 
practice and patient outcomes 
Competency - Collaborate in 
research and disseminate findings 
 
➢ Accountable for researching, planning, 
implementing, evaluating, and 
disseminating the project  
➢ Cited all work using APA 7th Edition 
➢ Utilized electronic health record to 
conduct chart reviews  
➢ Analyzed project data 
➢ Attended Vir-Mersion (both the online 
synchronous and nonsynchronous 
meetings) 
➢ Collaborated with the site champion, 
medical director, and university 
faculty member to design the project 
➢ Collaborated with the project site 
providers, assistive personnel, and 
office staff 
➢ Conducted PDSA cycle reviews to 
evaluate project processes 
➢ Used Excel to tabulate, analyze, create 
visual displays for, and the 
dissemination of the data for use in the 
paper and the poster 
➢ Used the three principles of ethics 
including respect for persons, 
beneficence, and justice to guide 
project development 
➢ Utilized web-based app 
➢ Retrieved electronic health record 
reports  










of Health Care 
Competency - Design/select and 
utilize software to analyze practice 
and consumer information 
systems that can improve the 
delivery & quality of care 
Competency - Analyze and 
operationalize patient care 
technologies 
Competency - Evaluate 
technology regarding ethics, 
efficiency, and accuracy 
Competency - Evaluates systems 
of care using health information 
technologies 
 
➢ Used computer software such as 
Microsoft Word, Excel, and 
PowerPoint and Adobe to produce 
scholarly paper, poster, and the pre-, 
intra-, and post-implementation 
reports related to the project 
➢ Submitted work through online, web-
based programs and plagiarism 
checkers as required by the university 
➢ Use of computer programs such as 
Microsoft Word, Excel, PowerPoint, 
and Chrome for project 
documentation, data collection, 
analysis, and dissemination 
➢ Used a virtual private network (VPN) 
to access the project site’s secure 
server and maintained all sensitive 
information on it 
➢ Use of online video conferencing 
programs such as Teams, WebEx, and 
Zoom 
➢ Utilized the health sciences library at 
the project lead’s university, including 
accessing scholarly databases Ovid, 
CINAHL, PubMed, ProQuest, and 
Google Scholar 
➢ Utilized teleconferencing and email to 
collaborate with the project site team 
members and university faculty 
member 
➢ Printed and laminated patient-facing 
materials that were provided by the 
affordable care organization and 
placed them in the exam rooms to 
trigger medication adherence 
conversations 
➢ Placed alerts on patient charts so that 
individual barriers could be assessed 
for individuals who were nonadherent 






Competency- Analyzes health 
policy from the perspective of 
patients, nursing, and other 
stakeholders 
➢ Implemented a tailored plan derived 
from current literature within the last 
five years 
➢ Provided leadership throughout the 
project to the project site during staff 
meetings, through policy changes, and 
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Competency – Provides 
leadership in developing and 
implementing health policy 
Competency –Influences 
policymakers, formally and 
informally, in local and global 
settings 
Competency – Educates 
stakeholders regarding policy 
Competency – Advocates for 
nursing within the policy arena 
Competency- Participates in 
policy agendas that assist with 
finance, regulation, and health 
care delivery 
Competency – Advocates for 
equitable and ethical health care 
conducted education to stakeholders at 
staff meetings to implement evidence-
based care 
➢ Demonstrated the value of advanced 
practice nursing, securing a second 
DNP project in the fall at the project 
site and the medical director is 
planning to take a third project 
afterwards 
➢ Presented the project to the affordable 
care organization that partners with the 
project site, who is interested in the 
results of the project to see if they may 
like to distribute it to other primary 
care offices within their network 
➢ Worked with the CEO, CNO, Director 
of Quality, and others at the local 
hospital for project development (first 
project)  
➢ Created a budget for the project 
➢ Performed a cost-benefit analysis to 
determine whether the project was 
“worth” the cost of implementation 
➢ Demonstrated the value of nursing 
leadership and impact on quality 









Competency- Uses effective 
collaboration and communication 
to develop and implement 
practice, policy, standards of care, 
and scholarship 
Competency – Provide leadership 
to interprofessional care teams 
Competency – Consult 
intraprofessionally and 
interprofessionally to develop 
systems of care in complex 
settings 
➢ Performed a peer review for the DNP 
project paper  
➢ Collaborated with graduate students 
during Immersion  
➢ Used library science to develop the 
research question and concept table to 
monitor the literature search 
➢ Kept a literature search log for 
replication if needed by another 
investigator 
➢ Obtained letter of support from the 
medical director 
➢ Collaborated with project site leaders 
such as nursing, billing, etc. 
➢ Obtained license for DOSE-
Nonadherence scale form from Duke 
University for project implementation 
through the project site and authorized 
by the site champion. 









epidemiology, biostatistics, and 
data to facilitate individual and 
population health care delivery 
Competency – Synthesizes 
information & cultural 
competency to develop & use 
health promotion/disease 
prevention strategies to address 
gaps in care 
Competency – Evaluates and 
implements change strategies of 
models of health care delivery to 
improve quality and address 
diversity 
➢ Investigated the population health 
statistics for the Tier 1 county that the 
project site is embedded in to 
understand the individual, social, 
cultural, and economic context for the 
project impact 
➢ Used the Health Belief Model to 
develop and guide interventions  
➢ Used the DOSE-Nonadherence tool 
➢ DNP project was a catalyst for 
creation of the Committee for Quality 
Measures and Incentives which was 
developed by the site champion in part 
due to project initiation  
➢ Used evidence-based 
recommendations for the project 





Competency- Melds diversity & 
cultural sensitivity to conduct 
systematic assessment of health 
parameters in varied settings 
Competency – Design, implement 
& evaluate nursing interventions 
to promote quality 
Competency – Develop & 
maintain patient relationships 
Competency –Demonstrate 
advanced clinical judgment and 
systematic thoughts to improve 
patient outcomes 
Competency – Mentor and 
support fellow nurses 
Competency- Provide support for 
individuals and systems 
experiencing change and 
transitions 
Competency –Use systems 
analysis to evaluate practice 
efficiency, care delivery, fiscal 
responsibility, ethical 
responsibility, and quality 
outcomes measures 
➢ Project lead recognizes that the project 
site’s patient populations represent 
several significant at-risk populations 
which demands culturally competent 
interventions 
➢ Created diver diagrams to guide 
primary and secondary drivers for star 
ratings 
➢ Evaluated project impact by analyzing 
the primary (star ratings) and 
secondary (process measures) drivers 
➢ Developed professional relationships 
with project site personnel 
➢ Demonstrated clinical judgement and 
systematic changes to improve the 
quality of care and improve patient 
outcomes 
➢ Performed education to providers, 
assistive personnel, and office staff – 
interprofessional collaboration 
➢ This project led to the opportunity to 
host other DNP projects for the 
university’s college of nursing 
➢ Leveraged stakeholder support 
 
